Key result
Mild or asymptomatic pediatric SARS-CoV-2 infection shows no short- or medium-term cardiorespiratory complications.
Why the study?
Protocols for safe return to competitive sports after SARS-CoV-2 infection have been developed for adults but not evaluated in children and adolescents.
Do children and adolescents with previous mild or asymptomatic SARS-CoV-2 infection show cardiorespiratory complications during return-to-play evaluation?
Observational (n=45)
No
Do children and adolescents with previous mild or asymptomatic SARS-CoV-2 infection show cardiorespiratory complications during return-to-play evaluation?
Mild or asymptomatic SARS-CoV-2 infection in children and adolescents does not appear to cause short- to medium-term cardiorespiratory complications, suggesting return to play is safe.
BACKGROUND: With the gradual resumption of sports activities after the lock-down period for coronavirus pandemic, a new problem is emerging: Allow all athletes to be able to return to compete after SARS-CoV-2 infection in total safety. Several protocols have been proposed for healed athletes but all of them have been formulated for the adult population. The aim of the present study is to evaluate the adequacy of Italian practical recommendations for return-to-paly, in order to exclude cardiorespiratory complications due to COVID-19 in children and adolescents. METHODS: Between April 2020 and January 2021 the Italian Sports Medical Federation formulated cardiorespiratory protocols to be applied to athletes recovered from SARS-CoV-2 infection. The protocols take into account the severity of the infection. Protocols include lung function tests, cardiopulmonary exercise test, echocardiographic evaluation, blood chemistry tests. RESULTS: From September 2020 to February 2021, 45 children and adolescents (aged from 9 to 18 years; male = 26) with previous SARS-CoV-2 infection were evaluated according to the protocols in force for adult. 55.5% of the subjects (N = 25) reported an asymptomatic infection; 44.5% reported a mild symptomatic infection. Results of lung function test have exceeded the limit of 80% of the theoretical value in all patients. The cardiorespiratory capacity of all patients was within normal limits (average value of maximal oxigen uptake 41 ml/kg/min). No arrhythmic events or reduction in the ejection fraction were highlighted. CONCLUSION: The data obtained showed that, in the pediatric population, mild coronavirus infection does not cause cardiorespiratory complications in the short and medium term. Return to play after Coronavirus infection seems to be safe but it will be necessary to continue with the data analysis in order to modulate and optimize the protocols especially in the pediatric field.
No takes yet. Share an insight, caveat, or question.
Cafiero et al. (2021) conducted an observational in Previous SARS-CoV-2 infection (n=45). SARS-CoV-2 infection was evaluated on Cardiorespiratory complications (lung function, cardiopulmonary exercise test, echocardiography). In children and adolescents recovered from mild or asymptomatic SARS-CoV-2 infection, cardiorespiratory capacity and lung function were within normal limits, indicating no short- or medium-term complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: